The Blog
-
Aug 13, 2025
Targeting RAS Mutations in Cancer: From Undruggable to Unstoppable Innovation
READ MORE -
Aug 12, 2025
Peptide-Based Cancer Inhibitors: The Future of Precision Oncology
READ MORE -
Jun 23, 2025
The Evolution of Bcr-Abl Inhibitors: From Imatinib to Next-Gen Therapies for CML and Beyond
READ MORE -
May 23, 2025
AZD0022 Explained: How AstraZeneca’s New Drug Could Transform Cancer Treatment
READ MORE -
May 16, 2025
AMG 410 and the Next Frontier in KRAS-Driven Cancer Treatment
READ MORE